Pexibrus 12.5 Tablet CR
By Pexibrus
Rx
10 Tablet CR in a Strip

Composition
Paroxetine(12.5mg)

Manufacturer - Med Manor Organics Pvt Ltd
16-11-477/45, Dilsukh Nagar, Hyderabad-500036, Telangana, India.

Expires on or after
October, 2025

liver
When using Pexibrus 12.5 Tablet CR, it is important to be cautious if you have liver disease. Patients with liver issues may require a dosage adjustment when taking Pexibrus 12.5 Tablet CR. Make sure to consult with your doctor regarding the use of this medication to ensure it is safe for your liver condition.

kidney
Caution should be exercised when using Pexibrus 12.5 Tablet CR in patients with kidney disease, as dosage adjustment may be necessary. It is advisable to consult your doctor for proper guidance.

alcohol
It is unsafe to drink alcohol while taking Pexibrus 12.5 Tablet CR.

driving
Caution should be exercised when driving as Pexibrus 12.5 Tablet CR may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these side effects.

pregnancy
Pexibrus 12.5 Tablet CR is not recommended during pregnancy due to potential harm to the developing baby based on studies. Consult your doctor before using.

breastfeeding
Pexibrus 12.5 Tablet CR is likely not safe during breastfeeding. Limited data indicates it may pass into breastmilk and could harm the baby.
Habit Forming | No |
Chemical Class | Phenylpiperidine Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Selective Seretonin Reuptake inhibitors (SSRIs) |
₹141
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024